Selective and Potent Inhibition of Human CYP2C19 Activity by a Conformationally Targeted Antipeptide Antibody
- 4 January 2025
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (7) , 715-717
- https://doi.org/10.1016/s0090-9556(24)15337-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Development of a Comprehensive Panel of Antibodies against the Major Xenobiotic Metabolising Forms of Cytochrome P450 in HumansBiochemical Pharmacology, 1998
- Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide,S-Mephenytoin, and Omeprazole HydroxylationsArchives of Biochemistry and Biophysics, 1998
- Targeted Antipeptide Antibodies to Cytochrome P450 2C18 Based on Epitope Mapping of an Inhibitory Monoclonal Antibody to P450 2C51Archives of Biochemistry and Biophysics, 1997
- Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activityJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Biochemistry and molecular biology of the human CYP2C subfamilyPharmacogenetics, 1994
- Isolation and Characterization of Human Liver Cytochrome P450 2C19: Correlation between 2C19 and S-Mephenytoin 4′-HydroxylationArchives of Biochemistry and Biophysics, 1993
- Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamilyBiochemistry, 1991
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins)Chemico-Biological Interactions, 1983